Halothane, surgery, immunosuppression and artificial pulmonary metastases.

Area of Science:

• Immunology
• Anesthesiology
• Cancer Metastasis

Background:

• Anesthesia and surgery can impact the immune system.
• The effects of perioperative interventions on cell-mediated cytotoxicity and tumor metastasis require further investigation.

Purpose of the Study:

• To investigate the impact of brief halothane anesthesia, alone and combined with surgery, on cell-mediated cytotoxicity and pulmonary metastasis in a mouse model.
• To evaluate the potential of thiabendazole (TBZ) as an immunopotentiator to counteract these effects.

Main Methods:

• C57B1/6 mice received intravenous tumor cells.
• Groups were exposed to halothane anesthesia alone or halothane anesthesia followed by hind limb amputation.
• Immune testing (cell-mediated cytotoxicity) and pulmonary metastasis assessment were performed at various time points.
• Thiabendazole (TBZ) was administered perioperatively in one group.

Main Results:

• A single 15-minute halothane exposure did not affect cell-mediated cytotoxicity or pulmonary metastases by day 7.
• Combined anesthesia and surgery significantly impaired cell-mediated cytotoxicity and increased pulmonary metastases.
• Perioperative administration of thiabendazole (TBZ) restored cell-mediated cytotoxicity and significantly reduced pulmonary metastases.

Conclusions:

• Brief halothane anesthesia alone has minimal short-term immunomodulatory effects.
• The combination of anesthesia and surgery can suppress cell-mediated immunity, promoting tumor metastasis.
• Thiabendazole (TBZ) shows potential as an immunotherapeutic agent to mitigate the adverse effects of surgery and anesthesia on anti-tumor immunity.